Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Icahn claims Illumina directors asked for insurance for Grail deal approval

Published 03/24/2023, 03:20 AM
Updated 03/24/2023, 04:30 PM
© Reuters. FILE PHOTO: Billionaire activist-investor Carl Icahn gives an interview on FOX Business Network's Neil Cavuto show in New York February 11, 2014.  REUTERS/Brendan McDermid (UNITED STATES)/File Photo
ILMN
-

(Reuters) -Carl Icahn on Friday came down heavily on Illumina Inc (NASDAQ:ILMN), saying its directors demanded extra personal liability insurance against any potential claims related to the acquisition of Grail in 2021 before agreeing to signing off on the deal.

In response to Icahn's claims, Illumina said insurance agreements with its directors were standard and it regularly reviews them to reflect appropriate coverage.

Activist investor Icahn, who owns 1.4% of Illumina, launched a proxy battle against the company earlier this month seeking divestment of cancer test developer Grail as the $7.1-billion acquisition cost investors billions of dollars.

The deal also faces antitrust opposition from the European Union, but that did not stop Illumina from going ahead and closing it. It was approved by the Federal Trade Commission in the United States in September last year.

A 2021 regulatory filing showed Illumina's directors entered into an additional insurance agreement that provides them protection from any potential claims related to the Grail deal, including those related to regulatory approvals.

"The timing of the agreement (a day before the Grail deal closed) and language around protection against personal liability related to acquisition hints that the BoD knew there were risks to the transaction," Evercore ISI analyst Vijay Kumar said.

© Reuters. FILE PHOTO: Billionaire activist-investor Carl Icahn gives an interview on FOX Business Network's Neil Cavuto show in New York February 11, 2014.  REUTERS/Brendan McDermid (UNITED STATES)/File Photo

Illumina has previously defended its decision to acquire Grail and rejected Icahn's allegations over the deal, saying it would divest Grail if it lost its appeal to the European Commission.

The company has appealed a European Union's planned order from December that would force Illumina to unwind its Grail deal.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.